Transcatheter arterial embolization with medical adhesive for nonvariceal gastrointestinal bleeding
Bin Cheng,Min Xu,Tianpeng Jiang,Jie Song,Tianzhi An,Shi Zhou
DOI: https://doi.org/10.11569/wcjd.v22.i5.735
2014-01-01
World Chinese Journal of Digestology
Abstract:Aim: To assess the clinical utility and safety of transcatheter arterial embolization with Fuaile medical adhesive (FAL) for control of arterial bleeding in the upper or lower gastrointestinal tract. Methods: Thirty-five patients with arterial bleeding of the gastrointestinal tract who underwent therapeutic transcatheter embolization using FAL during the period between October 2010 and June 2013 were retrospectively analyzed. Among the patients with upper gastrointestinal bleeding (n = 26), 5 had gastric ulcer, 7 had duodenal ulcer, 1 had pancreatic cancer, 4 had gastric cancer, 2 previously underwent suturing to stop bleeding gastric ulcer, 1 previously underwent surgery for duodenal ulcer, and 6 previously underwent gastrectomy. Among the patients with lower gastrointestinal bleeding (n = 9), 2 had jejunal cancer, 1 had ileal cancer, 2 had recurrent rectal cancer, 2 had recurrent colon cancer, and 2 had colorectal polyps. Superselective transcatheter arterial embolization with mixtures of FAL and iodized oil (1:1) was performed when the signs of bleeding was observed by radiography. Patient's blood pressure, heart rate, and hemoglobin level were assessed during 24 h before and after embolization. All the patients were followed for 1 year, and clinical effectiveness was evaluated and complications were analyzed. Results: Of 35 patients included, 33 were treated with FAL solely and 2 by FAL with microcoil. The rate of successful hemostasis was 100% (35/35). Four patients experienced rebleeding, of whom one had multiple ulcers and was retreated with coil and FAL successfully 6 days after the procedure, one who underwent gastrointestinal anastomosis was re-cured with FAL perfectly, and the other two died, one for pancreatic cancer three months after the embolization and one for massive rebleeding caused by pancreatic cancer and failed emergency surgery. Abdominal pain occurred in 5 patients, of whom 4 spontaneously relieved and 1 was referred to surgery for increased abdominal pain. Five patients died for cancer after the embolization during the follow-up and no rebleeding occurred. Conclusion: The results suggest that FAL can be a useful alternative embolic agent for the treatment of gastrointestinal bleeding, with a low rebleeding rate and incidence of complications if used properly. ? 2014 Baishideng Publishing Group Co., Limited. Allrights reserved.